awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q58720950-6B8D910C-38C2-42EC-9555-6CF40CDD8B36
Q58720950-6B8D910C-38C2-42EC-9555-6CF40CDD8B36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58720950-6B8D910C-38C2-42EC-9555-6CF40CDD8B36
A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome
P2860
Q58720950-6B8D910C-38C2-42EC-9555-6CF40CDD8B36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58720950-6B8D910C-38C2-42EC-9555-6CF40CDD8B36
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
984593c95a5affe184a6e25a9c5e65f966c6d4ad
P2860
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial